# Development of a Morphine Pharmacokinetic and Pharmacodynamic Model for the Neonatal Population

> **NCT03035578** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **The Hospital for Sick Children**

## Conditions studied

- Pain
- Drug Effect

## Interventions

- **DRUG:** Morphine
- **DRUG:** Morphine

## Key facts

- **NCT ID:** NCT03035578
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-12-01
- **Primary completion:** 2018-06-01
- **Final completion:** 2019-06-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** research project has been abandoned primarily because of the excessive delays associated with past challenges in obtaining approval from Health Canada
- **Last updated:** 2020-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03035578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03035578, "Development of a Morphine Pharmacokinetic and Pharmacodynamic Model for the Neonatal Population". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03035578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*